|
C8ORF37 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.901600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.123630E-01 |
| Normal-vs-Stage2 |
3.272800E-01 |
| Normal-vs-Stage3 |
2.059200E-01 |
| Normal-vs-Stage4 |
1.360780E-01 |
| Stage1-vs-Stage2 |
9.404400E-01 |
| Stage1-vs-Stage3 |
9.406800E-01 |
| Stage1-vs-Stage4 |
7.030600E-01 |
| Stage2-vs-Stage3 |
8.890200E-01 |
| Stage2-vs-Stage4 |
7.158600E-01 |
| Stage3-vs-Stage4 |
8.004200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.069160E-01 |
| Normal-vs-AfricanAmerican |
7.669600E-02 |
| Normal-vs-Asian |
4.561700E-02 |
| Caucasian-vs-AfricanAmerican |
6.724400E-01 |
| Caucasian-vs-Asian |
4.725800E-01 |
| AfricanAmerican-vs-Asian |
4.870200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.354160E-02 |
| Normal-vs-Female |
9.566000E-01 |
| Male-vs-Female |
6.136300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.360490E-02 |
| Normal-vs-Extreme_Weight |
3.793700E-02 |
| Normal-vs-Obese |
5.824000E-01 |
| Normal-vs-Extreme_Obese |
6.069400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.991000E-01 |
| Normal_Weight-vs-Obese |
7.312100E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.472200E-01 |
| Extreme_Weight-vs-Obese |
1.353780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.524600E-01 |
| Obese-vs-Extreme_Obese |
7.736000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.324400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.056600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.117100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.834100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.853800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.971200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.005800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.634300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.609000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.908400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.175600E-02 |
| Normal-VS-Type2 PRCC |
2.346400E-02 |
| Normal-VS-KIRP CIMP |
3.723200E-01 |
| Normal-VS-Unclassified PRCC |
9.900800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.402400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.081800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.375600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.272200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.876790E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.328000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.493850E-02 |
| Normal-vs-N1 |
2.618000E-01 |
| Normal-vs-N2 |
4.522800E-01 |
| N0-vs-N1 |
3.289800E-01 |
| N0-vs-N2 |
7.454000E-01 |
| N1-vs-N2 |
8.975400E-01 |
|
|
